Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
24
11
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
Two years ago, a 64-year-old man underwent an 18 F-FDG PET/CT for staging rectal cancer. Besides the hypermetabolic rectal lesion, the image revealed a mesenteric lymph node with intense activity and multiple lung nodules with slight FDG uptake, which were highly suspected of metastases. After surgery and multiple cycles of chemotherapy, the follow-up 18 F-FDG PET/CT showed remission of all lesions except for the enlarged mesenteric lymph node with higher metabolic activity. Serum CEA remained normal during the follow-up. Postoperative pathology of the mesenteric lymph node confirmed Castleman disease.
Identifiants
pubmed: 37703486
doi: 10.1097/RLU.0000000000004832
pii: 00003072-202311000-00021
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Radiopharmaceuticals
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
985-986Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: The authors declared no conflicts of interest. This work was funded by the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-070).
Références
Carbone A, Borok M, Damania B, et al. Castleman disease. Nat Rev Dis Primers . 2021;7:84.
Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood . 2020;135:1353–1364.
Cronin DMP, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol . 2009;16:236–246.
Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin North Am . 2018;32:37–52.
Koa B, Borja AJ, Aly M, et al. Emerging role of 18 F-FDG PET/CT in Castleman disease: a review. Insights Imaging . 2021;12:35.
Lee ES, Paeng JC, Park CM, et al. Metabolic characteristics of Castleman disease on 18 F-FDG PET in relation to clinical implication. Clin Nucl Med . 2013;38:339–342.
Wang W, Medeiros LJ. Castleman disease. Surg Pathol Clin . 2019;12:849–863.
Bhogal RH, Wotherspoon A, Khan AK. Mesenteric Castleman's disease mimicking neuroendocrine tumour. Int J Surg Case Rep . 2019;63:56–58.
Wu PS. Mesenteric Castleman's disease: report of a case and literature review. Int J Clin Exp Pathol . 2020;13:2397–2400.